![Mutations in genes required for T-cell development:IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review - ScienceDirect Mutations in genes required for T-cell development:IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1098360021038077-gr1.jpg)
Mutations in genes required for T-cell development:IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review - ScienceDirect
![Frontiers | A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening Frontiers | A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening](https://www.frontiersin.org/files/Articles/623199/fimmu-11-623199-HTML-r1/image_m/fimmu-11-623199-g001.jpg)
Frontiers | A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening
![IJNS | Free Full-Text | Newborn Screening for Severe Combined Immunodeficiency in the US: Current Status and Approach to Management IJNS | Free Full-Text | Newborn Screening for Severe Combined Immunodeficiency in the US: Current Status and Approach to Management](https://www.mdpi.com/IJNS/IJNS-03-00015/article_deploy/html/images/IJNS-03-00015-g004.png)
IJNS | Free Full-Text | Newborn Screening for Severe Combined Immunodeficiency in the US: Current Status and Approach to Management
![Adenosine Deaminase (ADA)–Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry | Journal of Clinical Immunology Adenosine Deaminase (ADA)–Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry | Journal of Clinical Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10875-020-00857-9/MediaObjects/10875_2020_857_Fig1_HTML.png)
Adenosine Deaminase (ADA)–Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry | Journal of Clinical Immunology
![Frontiers | Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network Frontiers | Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network](https://www.frontiersin.org/files/Articles/469175/fimmu-10-01908-HTML/image_m/fimmu-10-01908-g001.jpg)
Frontiers | Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network
![Mutations in genes required for T-cell development:IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review - ScienceDirect Mutations in genes required for T-cell development:IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1098360021038077-fx2.jpg)
Mutations in genes required for T-cell development:IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review - ScienceDirect
![Frontiers | Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease Frontiers | Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease](https://www.frontiersin.org/files/Articles/608653/fimmu-11-608653-HTML/image_m/fimmu-11-608653-g001.jpg)
Frontiers | Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease
![Adenosine Deaminase (ADA)–Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry | Journal of Clinical Immunology Adenosine Deaminase (ADA)–Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry | Journal of Clinical Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10875-020-00857-9/MediaObjects/10875_2020_857_Fig2_HTML.png)
Adenosine Deaminase (ADA)–Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry | Journal of Clinical Immunology
![Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency. - Abstract - Europe PMC Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3427915/bin/fimmu-03-00265-g005.jpg)
Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency. - Abstract - Europe PMC
![Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants - ScienceDirect Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022347697701999-gr1a.jpg)
Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants - ScienceDirect
![Adenosine Deaminase (ADA)–Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry | Journal of Clinical Immunology Adenosine Deaminase (ADA)–Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry | Journal of Clinical Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10875-020-00857-9/MediaObjects/10875_2020_857_Fig6_HTML.png)
Adenosine Deaminase (ADA)–Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry | Journal of Clinical Immunology
![Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety: Molecular Therapy Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety: Molecular Therapy](https://www.cell.com/cms/attachment/70ca7b2d-15f8-44a7-96db-6e06566d2c1b/gr1_lrg.jpg)
Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety: Molecular Therapy
![2020 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference | Journal of Clinical Immunology 2020 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference | Journal of Clinical Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10875-020-00764-z/MediaObjects/10875_2020_764_Figp_HTML.png)
2020 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference | Journal of Clinical Immunology
![IJNS | Free Full-Text | Newborn Screening for Severe Combined Immunodeficiency in the US: Current Status and Approach to Management IJNS | Free Full-Text | Newborn Screening for Severe Combined Immunodeficiency in the US: Current Status and Approach to Management](https://www.mdpi.com/IJNS/IJNS-03-00015/article_deploy/html/images/IJNS-03-00015-g002.png)